Sanyin Formula Enhances the Therapeutic Efficacy of Paclitaxel in Triple-Negative Breast Cancer Metastases through the JAK/STAT3 Pathway in Mice

Sanyin formula (SYF) is used as a complementary treatment for triple-negative breast cancer (TNBC). The purpose of this study was to identify the potential functional components and clarify the underlying molecular mechanisms of SYF in TNBC. High-performance liquid chromatography–tandem mass spectro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chunyu, Sun, Chenping, Han, Xianghui, Ye, Yiyi, Qin, Yuenong, Liu, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867389/
https://www.ncbi.nlm.nih.gov/pubmed/36678509
http://dx.doi.org/10.3390/ph16010009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867389/
https://www.ncbi.nlm.nih.gov/pubmed/36678509
http://dx.doi.org/10.3390/ph16010009

Ejemplares similares